HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development Study - Research Project Sites (Collaborative U01- Clinical Trial Not Allowed)

The HEAL Initiative: Limited Competition for the HEALthy Brain and Child Development Study - Research Project Sites is a federal funding opportunity administered by the National Institutes of Health within the U.S. Department of Health and Human Services. This program operates under the Helping to End Addiction Long-term Initiative, which is a trans-agency effort designed to accelerate scientific solutions to address the national opioid crisis and its long-term impacts. The specific focus of this funding opportunity is to support the continuation and renewal of research project sites participating in the HEALthy Brain and Child Development Study, a large-scale, longitudinal research effort examining early brain and behavioral development beginning at birth. The purpose of this funding opportunity is to sustain and expand the network of research project sites that collectively contribute to the HBCD Study. This nationwide initiative follows children from birth through early childhood to better understand the effects of prenatal substance exposure on developmental outcomes, including neurological, cognitive, behavioral, and physical health. The study is structured as a collaborative consortium consisting of research sites, a central administrative core, and a data coordinating center, all working in close coordination with NIH scientific staff. Funded research sites are expected to participate actively in consortium-wide planning, data sharing, and coordinated study protocols. Funding is provided through a cooperative agreement mechanism, which indicates substantial involvement from NIH staff in the conduct and oversight of funded activities. While specific award amounts are not detailed in the summary, the program anticipates making approximately 26 awards. Funds are intended to support comprehensive research activities aligned with the HBCD Study protocols, including participant recruitment, longitudinal data collection, neurodevelopmental assessments, and coordination with centralized data systems. There is no cost sharing or matching requirement associated with this funding opportunity. Eligibility for this program is highly restricted and operates as a limited competition. Only organizations or their subrecipients that were previously funded under specified prior funding announcements are eligible to apply. These include entities funded under RFA-DA-21-020 or RFA-DA-21-021. The opportunity allows participation from domestic and international organizations, including non-U.S. entities and foreign components of U.S. organizations, as defined by NIH policy. This ensures continuity and consistency in the research network while maintaining the integrity of longitudinal study data. The application process follows standard NIH submission and peer review procedures. Eligible applicants must submit complete proposals through the appropriate federal grant submission systems by the stated deadline. Applications are subject to rigorous peer review, and only those deemed meritorious based on scientific and programmatic criteria will be considered for funding. Applicants are expected to align closely with consortium requirements and demonstrate the capacity to contribute effectively to a collaborative, multi-site research effort. The funding opportunity was posted on June 10, 2026, with a final application deadline of July 10, 2026. Applications must be submitted by this closing date, and no rolling submissions are indicated. The timeline suggests a single-cycle competition for this renewal phase, with no explicit recurrence stated. Contact for program-related inquiries is available through an official NIH email address, ensuring applicants can seek clarification as needed. Overall, this opportunity represents a continuation of a major federal research initiative focused on understanding early development in the context of substance exposure and advancing public health knowledge.

Align proposal with consortium collaboration requirements and demonstrate ability to contribute to multi-site longitudinal research